Other Species / Isoforms
  PPP1CC (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
K6
__MADLDKLNIDSII
0 1
PPP1CC (human) __MADLDKLNIDSII K6
PPP1CC iso2 (human) __MADLDKLNIDSII K6
PPP1CC (mouse) __MADIDKLNIDSII K6
PPP1CC iso2 (mouse) __MADIDKLNIDSII K6
PPP1CC (rat) __MADIDkLNIDSII K6-ac
K6-ub
__MADLDkLNIDSII
0 4
PPP1CC (human) __MADLDkLNIDSII K6-ub
PPP1CC iso2 (human) __MADLDKLNIDSII K6
PPP1CC (mouse) __MADIDKLNIDSII K6
PPP1CC iso2 (mouse) __MADIDKLNIDSII K6
PPP1CC (rat) __MADIDKLNIDSII K6
S22-p
RLLEVRGskPGkNVQ
0 1
PPP1CC (human) RLLEVRGskPGkNVQ S22-p
PPP1CC iso2 (human) RLLEVRGSKPGKNVQ S22
PPP1CC (mouse) RLLEVRGSKPGkNVQ S22
PPP1CC iso2 (mouse) RLLEVRGSKPGKNVQ S22
PPP1CC (rat) RLLEVRGSKPGKNVQ S22
K23-ub
LLEVRGskPGkNVQL
0 1
PPP1CC (human) LLEVRGskPGkNVQL K23-ub
PPP1CC iso2 (human) LLEVRGSKPGKNVQL K23
PPP1CC (mouse) LLEVRGSKPGkNVQL K23
PPP1CC iso2 (mouse) LLEVRGSKPGKNVQL K23
PPP1CC (rat) LLEVRGSKPGKNVQL K23
K26-ub
VRGskPGkNVQLQEN
0 6
PPP1CC (human) VRGskPGkNVQLQEN K26-ub
PPP1CC iso2 (human) VRGSKPGKNVQLQEN K26
PPP1CC (mouse) VRGSKPGkNVQLQEN K26-ub
PPP1CC iso2 (mouse) VRGSKPGKNVQLQEN K26
PPP1CC (rat) VRGSKPGKNVQLQEN K26
R36-m1
QLQENEIrGLCLkSR
0 1
PPP1CC (human) QLQENEIrGLCLkSR R36-m1
PPP1CC iso2 (human) QLQENEIRGLCLKSR R36
PPP1CC (mouse) QLQENEIRGLCLKSR R36
PPP1CC iso2 (mouse) QLQENEIRGLCLKSR R36
PPP1CC (rat) QLQENEIRGLCLKSR R36
K41-ub
EIrGLCLkSREIFLs
0 3
PPP1CC (human) EIrGLCLkSREIFLs K41-ub
PPP1CC iso2 (human) EIRGLCLKSREIFLS K41
PPP1CC (mouse) EIRGLCLKSREIFLs K41
PPP1CC iso2 (mouse) EIRGLCLKSREIFLS K41
PPP1CC (rat) EIRGLCLKSREIFLs K41
S48-p
kSREIFLsQPILLEL
0 4
PPP1CC (human) kSREIFLsQPILLEL S48-p
PPP1CC iso2 (human) KSREIFLSQPILLEL S48
PPP1CC (mouse) KSREIFLsQPILLEL S48-p
PPP1CC iso2 (mouse) KSREIFLSQPILLEL S48
PPP1CC (rat) KSREIFLsQPILLEL S48-p
K60-ub
LELEAPLkICGDIHG
0 1
PPP1CC (human) LELEAPLkICGDIHG K60-ub
PPP1CC iso2 (human) LELEAPLKICGDIHG K60
PPP1CC (mouse) LELEAPLKICGDIHG K60
PPP1CC iso2 (mouse) LELEAPLKICGDIHG K60
PPP1CC (rat) LELEAPLKICGDIHG K60
Y93-p
NYLFLGDyVDRGkQS
0 1
PPP1CC (human) NYLFLGDyVDRGkQS Y93-p
PPP1CC iso2 (human) NYLFLGDYVDRGKQS Y93
PPP1CC (mouse) NYLFLGDYVDRGkQS Y93
PPP1CC iso2 (mouse) NYLFLGDYVDRGKQS Y93
PPP1CC (rat) NYLFLGDYVDRGKQS Y93
K98-ub
GDyVDRGkQSLETIC
0 23
PPP1CC (human) GDyVDRGkQSLETIC K98-ub
PPP1CC iso2 (human) GDYVDRGKQSLETIC K98
PPP1CC (mouse) GDYVDRGkQSLETIC K98-ub
PPP1CC iso2 (mouse) GDYVDRGKQSLETIC K98
PPP1CC (rat) GDYVDRGKQSLETIC K98
K113-ub
LLLAYKIkYPENFFL
0 7
PPP1CC (human) LLLAYKIkYPENFFL K113-ub
PPP1CC iso2 (human) LLLAYKIKYPENFFL K113
PPP1CC (mouse) LLLAYKIkYPENFFL K113-ub
PPP1CC iso2 (mouse) LLLAYKIKYPENFFL K113
PPP1CC (rat) LLLAYKIKYPENFFL K113
S129-p
RGNHECAsINRIyGF
0 4
PPP1CC (human) RGNHECAsINRIyGF S129-p
PPP1CC iso2 (human) RGNHECASINRIYGF S129
PPP1CC (mouse) RGNHECAsINRIYGF S129-p
PPP1CC iso2 (mouse) RGNHECASINRIYGF S129
PPP1CC (rat) RGNHECASINRIyGF S129
Y134-p
CAsINRIyGFyDECk
0 3
PPP1CC (human) CAsINRIyGFyDECk Y134-p
PPP1CC iso2 (human) CASINRIYGFYDECK Y134
PPP1CC (mouse) CAsINRIYGFyDECk Y134
PPP1CC iso2 (mouse) CASINRIYGFYDECK Y134
PPP1CC (rat) CASINRIyGFYDECK Y134-p
Y137-p
INRIyGFyDECkRRY
0 23
PPP1CC (human) INRIyGFyDECkRRY Y137-p
PPP1CC iso2 (human) INRIYGFYDECKRRY Y137
PPP1CC (mouse) INRIYGFyDECkRRY Y137-p
PPP1CC iso2 (mouse) INRIYGFYDECKRRY Y137
PPP1CC (rat) INRIyGFYDECKRRY Y137
K141-ac
yGFyDECkRRYNIkL
Upstream
0 25
Treatment
  • vorinostat
PPP1CC (human) yGFyDECkRRYNIkL K141-ac
PPP1CC iso2 (human) YGFYDECKRRYNIKL K141
PPP1CC (mouse) YGFyDECkRRYNIkL K141-ac
PPP1CC iso2 (mouse) YGFYDECKRRYNIKL K141
PPP1CC (rat) yGFYDECKRRYNIkL K141
K141-ub
yGFyDECkRRYNIkL
0 19
PPP1CC (human) yGFyDECkRRYNIkL K141-ub
PPP1CC iso2 (human) YGFYDECKRRYNIKL K141
PPP1CC (mouse) YGFyDECkRRYNIkL K141-ub
PPP1CC iso2 (mouse) YGFYDECKRRYNIKL K141
PPP1CC (rat) yGFYDECKRRYNIkL K141
K147-ac
CkRRYNIkLWkTFTD
0 3
PPP1CC (human) CkRRYNIkLWkTFTD K147-ac
PPP1CC iso2 (human) CKRRYNIKLWKTFTD K147
PPP1CC (mouse) CkRRYNIKLWkTFTD K147
PPP1CC iso2 (mouse) CKRRYNIKLWKTFTD K147
PPP1CC (rat) CKRRYNIkLWKTFTD K147-ac
K147-ub
CkRRYNIkLWkTFTD
0 9
PPP1CC (human) CkRRYNIkLWkTFTD K147-ub
PPP1CC iso2 (human) CKRRYNIKLWKTFTD K147
PPP1CC (mouse) CkRRYNIkLWkTFTD K147-ub
PPP1CC iso2 (mouse) CKRRYNIKLWKTFTD K147
PPP1CC (rat) CKRRYNIKLWKTFTD K147
K150-ub
RYNIkLWkTFTDCFN
0 6
PPP1CC (human) RYNIkLWkTFTDCFN K150-ub
PPP1CC iso2 (human) RYNIKLWKTFTDCFN K150
PPP1CC (mouse) RYNIkLWkTFTDCFN K150-ub
PPP1CC iso2 (mouse) RYNIKLWKTFTDCFN K150
PPP1CC (rat) RYNIkLWKTFTDCFN K150
Y255-p
HQVVEDGyEFFAkRQ
0 6
PPP1CC (human) HQVVEDGyEFFAkRQ Y255-p
PPP1CC iso2 (human) HQVVEDGYEFFAKRQ Y255
PPP1CC (mouse) HQVVEDGYEFFAkRQ Y255
PPP1CC iso2 (mouse) HQVVEDGYEFFAKRQ Y255
PPP1CC (rat) HQVVEDGYEFFAkRQ Y255
K260-ac
DGyEFFAkRQLVTLF
0 9
PPP1CC (human) DGyEFFAkRQLVTLF K260-ac
PPP1CC iso2 (human) DGYEFFAKRQLVTLF K260
PPP1CC (mouse) DGYEFFAkRQLVTLF K260-ac
PPP1CC iso2 (mouse) DGYEFFAKRQLVTLF K260
PPP1CC (rat) DGYEFFAkRQLVTLF K260-ac
K260-ub
DGyEFFAkRQLVTLF
0 39
PPP1CC (human) DGyEFFAkRQLVTLF K260-ub
PPP1CC iso2 (human) DGYEFFAKRQLVTLF K260
PPP1CC (mouse) DGYEFFAkRQLVTLF K260-ub
PPP1CC iso2 (mouse) DGYEFFAKRQLVTLF K260
PPP1CC (rat) DGYEFFAKRQLVTLF K260
K303-ub
LKPAEKKkPNAtRPV
0 1
PPP1CC (human) LKPAEKKkPNAtRPV K303-ub
PPP1CC iso2 (human) LKPAEKKKPNATRPV K303
PPP1CC (mouse) LKPAEKKKPNAtRPV K303
PPP1CC iso2 (mouse) LKPAEKKKPNATRPV K303
PPP1CC (rat) LKPAEKKKPNATRPV K303
T307-p
EKKkPNAtRPVtPPR
Upstream
Downstream
1 6
Effects on Modified Protein
  • enzymatic activity, inhibited
Kinase, in vitro:
  • NEK2 (human)
PPP1CC (human) EKKkPNAtRPVtPPR T307-p
PPP1CC iso2 (human) EKKKPNATRPVtPPR T307
PPP1CC (mouse) EKKKPNAtRPVtPPR T307-p
PPP1CC iso2 (mouse) EKKKPNATRPVTPPR T307
PPP1CC (rat) EKKKPNATRPVTPPR T307
T311-p
PNAtRPVtPPRGMIt
Upstream
Downstream
1 36
Effects on Modified Protein
  • enzymatic activity, inhibited
Regulatory protein:
  • ATR (human)
  • CDK1 (human)
  • CDK2 (human)
Treatment
  • caffeine
  • purvalanol
  • UV
PPP1CC (human) PNAtRPVtPPRGMIt T311-p
PPP1CC iso2 (human) PNATRPVtPPRVASG T311-p
PPP1CC (mouse) PNAtRPVtPPRGMIT T311-p
PPP1CC iso2 (mouse) PNATRPVTPPRVGSG T311
PPP1CC (rat) PNATRPVTPPRGMIT T311
T318-p
tPPRGMItkQAkK__
Upstream
Downstream
1 1
Effects on Modified Protein
  • enzymatic activity, inhibited
Kinase, in vitro:
  • NEK2 (human)
PPP1CC (human) tPPRGMItkQAkK__ T318-p
PPP1CC iso2 (human) gap -
PPP1CC (mouse) tPPRGMITkQAKK__ T318
PPP1CC iso2 (mouse) gap -
PPP1CC (rat) TPPRGMITKQAKK__ T318
K319-ub
PPRGMItkQAkK___
0 2
PPP1CC (human) PPRGMItkQAkK___ K319-ub
PPP1CC iso2 (human) gap -
PPP1CC (mouse) PPRGMITkQAKK___ K319-ub
PPP1CC iso2 (mouse) gap -
PPP1CC (rat) PPRGMITKQAKK___ K319
K322-m1
GMItkQAkK______
0 1
PPP1CC (human) GMItkQAkK______ K322-m1
PPP1CC iso2 (human) gap -
PPP1CC (mouse) GMITkQAKK______ K322
PPP1CC iso2 (mouse) gap -
PPP1CC (rat) GMITKQAKK______ K322